Literature DB >> 11531797

Staphylococcus aureus enterotoxins induce histamine and leukotriene release in patients with atopic eczema.

J Wehner1, K Neuber.   

Abstract

BACKGROUND: Chronic skin colonization with Staphylococcus aureus is a characteristic feature of atopic eczema (AE), and about 60% of S. aureus strains isolated from the skin of patients with AE secrete enterotoxins. Furthermore, IgE antibodies to S. aureus enterotoxins have been identified in 78% of patients with AE.
OBJECTIVES: To examine the S. aureus enterotoxin-induced histamine and leukotriene release of basophils from patients with AE.
METHODS: Peripheral blood basophils from patients with AE were stimulated with the staphylococcal enterotoxins A, B, D, E and toxic shock syndrome toxin-1. Additionally, priming experiments were performed with interleukin (IL)-3, IL-8 and granulocyte/macrophage colony-stimulating factor followed by stimulation with S. aureus enterotoxins.
RESULTS: In patients with AE, basophils secreted significantly higher amounts of histamine and leukotriene C4 (LTC4) than in healthy controls. The priming experiments showed additional histamine and LTC4 release in the group of AE patients.
CONCLUSIONS: Histamine and leukotriene generation from atopic basophils stimulated with staphylococcal enterotoxins may indicate a role for these toxins as possible allergens in at least a subgroup of patients with AE.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11531797     DOI: 10.1046/j.1365-2133.2001.04352.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  13 in total

Review 1.  Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms.

Authors:  Peter M Elias; Yutaka Hatano; Mary L Williams
Journal:  J Allergy Clin Immunol       Date:  2008-03-07       Impact factor: 10.793

Review 2.  Abnormal skin barrier in the etiopathogenesis of atopic dermatitis.

Authors:  Peter M Elias; Matthias Schmuth
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

Review 3.  Lipid abnormalities and lipid-based repair strategies in atopic dermatitis.

Authors:  Peter M Elias
Journal:  Biochim Biophys Acta       Date:  2013-10-12

Review 4.  Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis.

Authors:  Peter M Elias; Joan S Wakefield
Journal:  Clin Rev Allergy Immunol       Date:  2011-12       Impact factor: 8.667

5.  Encoding a superantigen by Staphylococcus aureus does not affect clinical characteristics of infected atopic dermatitis lesions.

Authors:  A Kozman; Y Yao; P Bina; C Saha; W Yao; M H Kaplan; J B Travers
Journal:  Br J Dermatol       Date:  2010-12       Impact factor: 9.302

6.  Therapeutic Implications of a Barrier-based Pathogenesis of Atopic Dermatitis.

Authors:  Peter M Elias
Journal:  Ann Dermatol       Date:  2010-08-05       Impact factor: 1.444

Review 7.  Abnormal skin barrier in the etiopathogenesis of atopic dermatitis.

Authors:  Peter M Elias; Matthias Schmuth
Journal:  Curr Opin Allergy Clin Immunol       Date:  2009-10

8.  Direct, Specific and Rapid Detection of Staphylococcal Proteins and Exotoxins Using a Multiplex Antibody Microarray.

Authors:  Bettina Stieber; Stefan Monecke; Elke Müller; Joseph Büchler; Ralf Ehricht
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

9.  Association of specific IgE to staphylococcal superantigens with the phenotype of chronic urticaria.

Authors:  Young-Min Ye; Gyu-Young Hur; Han-Jung Park; Seung-Hyun Kim; Hyun-Mi Kim; Hae-Sim Park
Journal:  J Korean Med Sci       Date:  2008-10       Impact factor: 2.153

10.  Interaction between antibiotic use and MS4A2 gene polymorphism on childhood eczema: a prospective birth cohort study.

Authors:  Li Hua; Qian Chen; Quan-Hua Liu; Yi-Feng Guo; Ru-Hong Cheng; Jun Zhang; Jian-Hua Zhang; Li-Wei Wang; Ruo-Xu Ji
Journal:  BMC Pediatr       Date:  2021-07-14       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.